Strong volume, pricing, and margin execution drove another guidance raise, though investments and EHR implementation create near-term profitability risks.
| Quarter | Q2 FY26 |
|---|---|
| Call date | 2026-08-06 |
| Length | 52 minutes |
| EPS | $0.06 |
| EPS consensus | $0.03 |
| Revenue | $435.4M |
What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.
All LFST earnings ยท Back to LFST overview
Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.